These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 19570818

  • 21. Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.
    De Stefano N, Filippi M, Hawkins C, 9011 study group.
    J Neurol Sci; 2008 Mar 15; 266(1-2):44-50. PubMed ID: 17897678
    [Abstract] [Full Text] [Related]

  • 22. Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
    Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T, Laquinimod in Relapsing MS Study Group.
    Neurology; 2005 Mar 22; 64(6):987-91. PubMed ID: 15781813
    [Abstract] [Full Text] [Related]

  • 23. Segmentation of gadolinium-enhanced lesions on MRI in multiple sclerosis.
    Datta S, Sajja BR, He R, Gupta RK, Wolinsky JS, Narayana PA.
    J Magn Reson Imaging; 2007 May 22; 25(5):932-7. PubMed ID: 17457804
    [Abstract] [Full Text] [Related]

  • 24. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Birnbaum G, Cree B, Altafullah I, Zinser M, Reder AT.
    Neurology; 2008 Oct 28; 71(18):1390-5. PubMed ID: 18525027
    [Abstract] [Full Text] [Related]

  • 25. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
    Schocke MF, Berger T, Felber SR, Wolf C, Deisenhammer F, Kremser C, Seppi K, Aichner FT.
    Neuroimage; 2003 Oct 28; 20(2):1253-63. PubMed ID: 14568494
    [Abstract] [Full Text] [Related]

  • 26. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.
    Harris JO, Frank JA, Patronas N, McFarlin DE, McFarland HF.
    Ann Neurol; 1991 May 28; 29(5):548-55. PubMed ID: 1859184
    [Abstract] [Full Text] [Related]

  • 27. Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy.
    Berger JR.
    Mult Scler; 2008 Jun 28; 14(5):708-10. PubMed ID: 18566035
    [Abstract] [Full Text] [Related]

  • 28. Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
    Cohen JA, Imrey PB, Calabresi PA, Edwards KR, Eickenhorst T, Felton WL, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Mandell BF, Scott TF, Zhang H, Apperson-Hansen C, Beck GJ, Houghtaling PL, Karafa MT, Stadtler M, ACT Investigators.
    Neurology; 2009 Feb 10; 72(6):535-41. PubMed ID: 19204263
    [Abstract] [Full Text] [Related]

  • 29. Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis.
    Cocco E, Marchi P, Sardu C, Russo P, Paolillo A, Mascia M, Solla M, Frau J, Lorefice L, Massole S, Floris G, Marrosu M.
    Mult Scler; 2007 Sep 10; 13(8):975-80. PubMed ID: 17468439
    [Abstract] [Full Text] [Related]

  • 30. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A, Hreha S, Berger JR, Bao F, Penmesta R, Tselis A, Endress C, Zak I, Perumal J, Caon C, Vazquez J, Tyler KL, Racke MK, Millis S, Khan O.
    Arch Neurol; 2009 May 10; 66(5):593-9. PubMed ID: 19433659
    [Abstract] [Full Text] [Related]

  • 31. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
    Metz LM, Zhang Y, Yeung M, Patry DG, Bell RB, Stoian CA, Yong VW, Patten SB, Duquette P, Antel JP, Mitchell JR.
    Ann Neurol; 2004 May 10; 55(5):756. PubMed ID: 15122721
    [No Abstract] [Full Text] [Related]

  • 32. Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.
    Cohen JA, Calabresi PA, Chakraborty S, Edwards KR, Eickenhorst T, Felton WL, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Imrey PB, Ivancic DM, Mandell BF, Perryman JE, Scott TF, Skaramagas TT, Zhang H, ACT Investigators.
    Mult Scler; 2008 Apr 10; 14(3):370-82. PubMed ID: 18208877
    [Abstract] [Full Text] [Related]

  • 33. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
    Hermann KG, Landewé RB, Braun J, van der Heijde DM.
    J Rheumatol; 2005 Oct 10; 32(10):2056-60. PubMed ID: 16206370
    [Abstract] [Full Text] [Related]

  • 34. MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.
    Sormani MP, Bruzzi P.
    Lancet Neurol; 2013 Jul 10; 12(7):669-76. PubMed ID: 23743084
    [Abstract] [Full Text] [Related]

  • 35. [Open trial of the effectiveness of interferon beta 1a (Avonex) in the treatment of multiple sclerosis in Poland: MRI results].
    Siger-Zajdel M, Lewańska M, Zaleski K, Członkowska A, Kwieciński H, Losy J, Podemski R, Stelmasiak Z, Selmaj K.
    Neurol Neurochir Pol; 2003 Jul 10; 37(6):1185-97. PubMed ID: 15174232
    [Abstract] [Full Text] [Related]

  • 36. Magnetisation transfer imaging in multiple sclerosis.
    Filippi M, Rovaris M.
    J Neurovirol; 2000 May 10; 6 Suppl 2():S115-20. PubMed ID: 10871798
    [Abstract] [Full Text] [Related]

  • 37. Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS.
    Cohen JA, Rovaris M, Goodman AD, Ladkani D, Wynn D, Filippi M, 9006 Study Group.
    Neurology; 2007 Mar 20; 68(12):939-44. PubMed ID: 17372130
    [Abstract] [Full Text] [Related]

  • 38. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M, Schwarcz A, Randhawa MS, Marton B, Kardos L, Palkó A.
    Eur J Radiol; 2008 Jan 20; 65(1):133-9. PubMed ID: 17485189
    [Abstract] [Full Text] [Related]

  • 39. Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
    Livshits I, Hussein S, Kennedy C, Weinstock-Guttman B, Hojnacki D, Zivadinov R.
    Minerva Med; 2012 Apr 20; 103(2):97-102. PubMed ID: 22513514
    [Abstract] [Full Text] [Related]

  • 40. [MRI visualization of multiple sclerosis lesions].
    Berry I, Ranjeva JP, Manelfe C, Clanet M.
    Rev Neurol (Paris); 1998 Sep 20; 154(8-9):607-17. PubMed ID: 9809376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.